[
  {
    "ts": null,
    "headline": "Boston Scientific Corp. stock outperforms competitors on strong trading day",
    "summary": "Boston Scientific Corp. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=f85d13b7fb1094887f9bc197343569c9e5635b8fd4e4eb02e15d06bc1d8e3202",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731343260,
      "headline": "Boston Scientific Corp. stock outperforms competitors on strong trading day",
      "id": 131416663,
      "image": "",
      "related": "BSX",
      "source": "MarketWatch",
      "summary": "Boston Scientific Corp. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=f85d13b7fb1094887f9bc197343569c9e5635b8fd4e4eb02e15d06bc1d8e3202"
    }
  },
  {
    "ts": null,
    "headline": "INGN Stock Gains Following Q3 Earnings Beat, Adjusted Gross Margin Up",
    "summary": "Inogen's overall third-quarter 2024 results continue to gain from higher business-to-business sales.",
    "url": "https://finnhub.io/api/news?id=5353cdc6762f185242b97286b4c5c4a16c984c06a7b2ce60bcd7ed2ed0575f40",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731339000,
      "headline": "INGN Stock Gains Following Q3 Earnings Beat, Adjusted Gross Margin Up",
      "id": 131287037,
      "image": "https://media.zenfs.com/en/zacks.com/32e3eb8c0cc46c163964cde251fb4426",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Inogen's overall third-quarter 2024 results continue to gain from higher business-to-business sales.",
      "url": "https://finnhub.io/api/news?id=5353cdc6762f185242b97286b4c5c4a16c984c06a7b2ce60bcd7ed2ed0575f40"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific resumes enrolment in pulsed field ablation trial",
    "summary": "Boston Scientific temporarily paused enrolment in its AVANT GUARD trial in October to “assess a few unanticipated observations”.",
    "url": "https://finnhub.io/api/news?id=8e37606a1acdefbfce9077842060f821c7cd40b322ae6efba472d9d293723296",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731330873,
      "headline": "Boston Scientific resumes enrolment in pulsed field ablation trial",
      "id": 131297542,
      "image": "",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Boston Scientific temporarily paused enrolment in its AVANT GUARD trial in October to “assess a few unanticipated observations”.",
      "url": "https://finnhub.io/api/news?id=8e37606a1acdefbfce9077842060f821c7cd40b322ae6efba472d9d293723296"
    }
  },
  {
    "ts": null,
    "headline": "Haemonetics' Q2 Earnings and Revenues Top, Stock Up, Margins Expand",
    "summary": "HAE delivers impressive growth in the top and bottom lines in the second quarter of fiscal 2025.",
    "url": "https://finnhub.io/api/news?id=8b7291ff675ce11de52f266359e3fddbab305f18cef6644c20f169a253c0f3da",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731329820,
      "headline": "Haemonetics' Q2 Earnings and Revenues Top, Stock Up, Margins Expand",
      "id": 131287241,
      "image": "https://media.zenfs.com/en/zacks.com/3136c22cf05e163ab2bb94a2755707e9",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "HAE delivers impressive growth in the top and bottom lines in the second quarter of fiscal 2025.",
      "url": "https://finnhub.io/api/news?id=8b7291ff675ce11de52f266359e3fddbab305f18cef6644c20f169a253c0f3da"
    }
  }
]